HHS/FDA Ephedra Strategy: A Risk Management Approach?
This article was originally published in The Tan Sheet
Executive Summary
HHS Secretary Tommy Thompson is urging manufacturers of ephedrine alkaloid supplements to include FDA's MedWatch toll-free number on labeling to better enable consumer reporting of adverse events